Log In
Print
BCIQ
Print
Print this Print this
 

AD04

  Manage Alerts
Collapse Summary General Information
Company ADial Pharmaceuticals LLC
DescriptionUltra low-dose formulation of ondansetron, a generic serotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAddiction
Indication DetailsTreat alcohol use disorder
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today